drugset / Trial / NCT06755151
Fenofibrate in Primary Biliary Cholangitis: a Real World Study
NaSingle-groupOpen-labelTreatment
Summary
An Open Label Long-Term Study to Evaluate the Safety and Tolerability of Fenofibrate in Combination with Ursodeoxycholic Acid in Subjects with Primary Biliary Cholangitis (PBC)
Timeline
- Start
- 2024-01-17
- Primary completion
- 2035-12
- Completion
- 2035-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fenofibrate | Small molecule | 200 mg | — |